Strong expression of CD133 is associated with increased cholangiocarcinoma progression

doi:10.3748/wjg.v17.i9.1192

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3353)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

344

HTML

2728

Figures (1-5)

132

Tables (1-2)

149

Sum=3353

Mar 7, 2011 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 7, 2011; 17(9): 1192-1198
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1192

Full Size Figure Download Figure

Figure 1 Representative immunohistochemical staining for CD133 in cholangiocarcinoma specimens. A: Normal bile duct cells (red arrow) demonstrated negative staining, whereas cholangiocarcinoma cells had strong cytoplasmic staining (black arrow); B: Moderately differentiated cholangiocarcinoma with overexpression of CD133. Positive staining was observed in the cytoplasm of cholangiocarcinoma cells (200 × magnification).

Citation: Leelawat K, Thongtawee T, Narong S, Subwongcharoen S, Treepongkaruna SA. Strong expression of CD133 is associated with increased cholangiocarcinoma progression. World J Gastroenterol 2011; 17(9): 1192-1198
URL: https://www.wjgnet.com/1007-9327/full/v17/i9/1192.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i9.1192